22:25:08 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Cannabis Summary for July 17, 2019

2019-07-17 20:16 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index jumped 20.69 points to 615.50 Wednesday. Curaleaf Holdings Inc. (CURA) surged $1.46 to $9.95 on 6.49 million shares after signing a definitive agreement to acquire GR Companies Inc. (known as Grassroots) for $875-million. Grassroots has 61 dispensary licences and 20 operating dispensaries today. Grassroots operates in states that Curaleaf is not yet in, including Illinois, which became the 11th state to legalize recreational cannabis in June, Pennsylvania, Arkansas, Michigan, North Dakota, Oklahoma and Vermont. The acquisition would expand Curaleaf's presence to 19 states, up from 12, and to 68 operating dispensaries, up from 48.

The $875-million purchase price is to be fulfilled through a $75-million cash payment, a 102.8-million-share issuance of Curaleaf and a final $40-million payment. The final payment will also be Curaleaf shares, priced at the 10-day volume weighted average price prior to the close of the deal (Curaleaf expects the deal to close in early 2020). As a result of the share issuances, Grassroots shareholders will own approximately 16 per cent of Curaleaf on a fully diluted basis (implying Curaleaf will have just under 950 million shares outstanding when fully diluted). As part of the agreement, Grassroots will appoint its co-founder and chief executive officer, Mitch Kahn, as a director of Curaleaf.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed